Fertility preservation technology has been developed primarily as a treatment for women with malignancy, or other medical conditions, where the disease or treatment pose a threat to the women's future fertility. Given revolutionary advances in vitrification methods for cryopreservation of oocytes, the option of oocyte cryopreservation for personal, or non-medical indications has been offered in several countries. Israel endorsed oocyte cryopreservation for non-medical indications in 2010. This article explores the Israeli perspective and its associated social implications.
|Number of pages||6|
|Journal||Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie|
|State||Published - 1 Oct 2014|
- Oocyte cryopreservation